Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
24 participants
INTERVENTIONAL
2013-10-31
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Aerobic exercise
30 minutes x 3 times/week x 12 weeks of stationery cycling
Aerobic exercise
Non-aerobic exercise
30 minutes x 3 times/week x 12 weeks of gentle non-aerobic stretching
Placebo control
Non-aerobic stretching sessions will be conducted 3x/week for 30 minutes over 12 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aerobic exercise
Placebo control
Non-aerobic stretching sessions will be conducted 3x/week for 30 minutes over 12 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* MRI compatibility
* Right Handed
Exclusion Criteria
* History of pulmonary disease, heart disease, vascular disease of the legs, high blood pressure
* History of stroke, other neurological disease/disorder, serious psychiatric illness
* Engaging in more than 30 minutes of aerobic exercise per week
* Current use of steroids, benzodiazepines, and/or neuroleptics
* History of substance abuse
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
New Jersey Commission on Brain Injury Research
OTHER
Kessler Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Victoria Leavitt
Research Scientist
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R-687-11
Identifier Type: -
Identifier Source: org_study_id